Last update 09 Oct 2026

Ukaize Biopharmaceuticals Shanghai Co. Ltd.

Subsidiary Company|2024|Shanghai Shi, China

Overview

Tags

Hemic and Lymphatic Diseases
Neoplasms
Immune System Diseases
Universal CAR-T

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Hemic and Lymphatic Diseases2
Neoplasms2
Immune System Diseases2
Nervous System Diseases1
Top 5 Drug TypeCount
Universal CAR-T2
Top 5 TargetCount
CD19 x CD201
BCMA(B-cell maturation protein)1

Related

2
Drugs associated with Ukaize Biopharmaceuticals Shanghai Co. Ltd.
KJ-C2219
Target
CD19 x CD20
Mechanism
CD19 inhibitors [+1]
Active Org.
Shanghai Tongji Hospital [+3]
Originator Org.
CARsgen Therapeutics Co. Ltd.CARsgen Therapeutics Co. Ltd.
Active Indication
Mediastinal large B-cell lymphoma [+13]
Inactive Indication-
Drug Highest PhasePhase 1/2
First Approval Ctry. / Loc.-
First Approval Date-
CT0596 CAR-T Cell
Target
BCMA
Mechanism
BCMA inhibitors
Active Org.
Ukaize Biopharmaceuticals Shanghai Co. Ltd. [+2]
Originator Org.
CARsgen Therapeutics Co. Ltd.CARsgen Therapeutics Co. Ltd.
Active Indication
Refractory Multiple Myeloma [+2]
Inactive Indication-
Drug Highest PhasePhase 1/2
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with Ukaize Biopharmaceuticals Shanghai Co. Ltd.
CTR20263465
/ RecruitingPhase 1
一项评估CT1190B在复发/难治大B细胞淋巴瘤患者中安全性、有效性和细胞代谢动力学的I/II期临床试验
[Translation] A phase I/II clinical trial evaluating the safety, efficacy, and cellular metabolic kinetics of CT1190B in patients with relapsed/refractory large B-cell lymphoma.
100 Clinical Results associated with Ukaize Biopharmaceuticals Shanghai Co. Ltd.
Login to view more data
0 Patents (Medical) associated with Ukaize Biopharmaceuticals Shanghai Co. Ltd.
Login to view more data
100 Deals associated with Ukaize Biopharmaceuticals Shanghai Co. Ltd.
Login to view more data
100 Translational Medicine associated with Ukaize Biopharmaceuticals Shanghai Co. Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 09 Oct 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 1
1
1
Phase 2
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
CT0596 CAR-T Cell
 ( BCMA )		Refractory Multiple Myeloma
More
Phase 1/2
KJ-C2219
 ( CD19 x CD20 )		Large B-cell lymphoma
More
Phase 1
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free